Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052) [Phase 2]
Phase 2 trial evaluating temozolomide in previously untreated acute myeloid leukemia and myelodysplastic syndrome patients with low MGMT exp…
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome [Phase 2]
This is a Phase 2 clinical trial evaluating idarubicin, cytarabine, and gemtuzumab ozogamicin in patients with previously untreated high-ris…
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating gemtuzumab ozogamicin with or without chemotherapy in older patients with acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B) [Phase 3]
Phase III randomized trial AML-8B evaluating intensive consolidation with high-dose cytarabine in acute myeloid leukemia has completed. The …
-
CLINICAL_TRIALS trial_result · 2012-07-13Clinical Trial Update: Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006) [Phase 1, Phase 2]
Phase I/II trial evaluating idarubicin, cytarabine, and sorafenib in acute myeloid leukemia and related myeloid disorders; study completed w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-07-09Clinical Trial Update: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant [NA]
A clinical trial evaluating mechanical stimulation to prevent bone density loss in patients undergoing donor stem cell transplant has been w…
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients [Phase 3]
Phase 3 clinical trial evaluating decitabine for untreated adult acute myeloid leukemia in elderly patients, assessing therapeutic effect an…
-
CLINICAL_TRIALS trial_result · 2012-07-03Clinical Trial Update: A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT [Phase 1]
A Phase 1 dose-escalation study evaluating safety and pharmacokinetics of Palifermin in subjects with acute leukemia undergoing hematopoieti…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia [Phase 3]
This Phase 3 trial compares combination chemotherapy with or without granulocyte colony-stimulating factor (G-CSF) in older patients with ac…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia [Phase 2]
Phase 2 clinical trial evaluating interleukin-2 in relapsed or refractory acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML [Phase 2]
Phase 2 clinical trial evaluating the safety and anti-disease activity of oral tosedostat (CHR-2797) in elderly patients with refractory or …
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating conditioning with busulfan and cyclophosphamide followed by bone marrow transplantation in patients with acute myel…
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 trial update evaluating chemotherapy plus bone marrow transplantation with filgrastim in patients with acute myeloid leukemia or mye…
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial investigated arsenic trioxide in patients with acute myeloid leukemia and the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Unrelated Double Umbilical Cord Blood Units Transplantation [Phase 2, Phase 3]
Update on a Phase 2/3 trial evaluating unrelated double umbilical cord blood transplantation for acute and chronic leukemias, sponsored by T…
-
CLINICAL_TRIALS research · 2012-05-23Clinical Trial Update: Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents [Phase 2, Phase 3]
This is a Phase 2/Phase 3 trial update evaluating therapy optimization for acute myeloid leukemia in children and adolescents; no results or…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Busulfan and Fludarabine in Patients With AML and MDS [Phase 2]
Phase 2 trial evaluating a busulfan and fludarabine regimen in patients with acute myeloid leukemia and myelodysplastic syndrome has complet…
-
CLINICAL_TRIALS research · 2012-05-07Clinical Trial Update: F18-FLT PET/CT as a Tool for Assessment of Myeloablative Treatment in Patients With Acute Myeloid Leucemia(AML)
This entry reports on a clinical trial evaluating F18-FLT PET/CT as a tool to assess the effectiveness of myeloablative treatment in patient…
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5 [Phase 2]
Phase 2 clinical trial update assessing lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with deletion 5q or mo…
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia [Phase 1]
A Phase 1 trial evaluating the combination of clofarabine and cytarabine in older adults with acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies [Phase 1, Phase 2]
This document provides an update on the completed Phase 1/2 trial of SB1518 for advanced myeloid malignancies.
-
CLINICAL_TRIALS trial_result · 2012-04-13Clinical Trial Update: Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy [Phase 2]
Phase 2 clinical trial update for Acute Myeloid Leukemia patients undergoing induction chemotherapy, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-13Clinical Trial Update: High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia [Phase 3]
Phase 3 clinical trial update evaluating high-dose chemotherapy with peripheral stem cell transplantation and interleukin-2 for acute myeloi…
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies [Phase 1, Phase 2]
This clinical trial update reports safety and early efficacy data for unrelated cord blood transplantation in adults with hematologic malign…
-
CLINICAL_TRIALS trial_result · 2012-03-27Clinical Trial Update: Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic Syndromes [Phase 1]
Phase 1 dose-escalation and safety/pharmacokinetic study of SAR103168 in patients with refractory/relapsed acute myeloid leukemia and high-r…